Literature DB >> 16329085

Improved R2* measurements in myocardial iron overload.

Nilesh R Ghugre1, Cathleen M Enriquez, Thomas D Coates, Marvin D Nelson, John C Wood.   

Abstract

PURPOSE: To optimize R2*(1/T2*) measurements for cardiac iron detection in sickle cell and thalassemia patients.
MATERIALS AND METHODS: We studied 31 patients with transfusion-dependent sickle cell disease and 48 patients with thalassemia major; myocardial R2* was assessed in a single midpapillary slice using a gated gradient-echo pulse sequence. Pixel-wise maps were coregistered among the patients to determine systematic spatial fluctuations in R2*. The contributions of minimum TE, echo spacing, signal-decay model, and region-of-interest (ROI) choice were compared in synthetic and acquired images.
RESULTS: Cardiac relaxivity demonstrated characteristic circumferential variations regardless of the degree of iron overload. Within the interventricular septum, a gradient in R2* from right to left ventricle was noted at high values. Pixel-wise and ROI techniques yielded nearly identical values. Signal decay was exponential but a constant offset or second exponential term was necessary to avoid underestimation at high iron concentration. Systematic underestimation of R2* was observed for higher minimum TE, limiting the range of iron concentrations that can be profiled. Fat-water oscillations, although detectable, represented only 1% of the total signal.
CONCLUSION: Clinical cardiac R2* measurements should be restricted to the interventricular septum and should have a minimum TE < or = 2 msec. ROI analysis techniques are accurate; however, offset-correction is essential.

Entities:  

Mesh:

Year:  2006        PMID: 16329085      PMCID: PMC2892961          DOI: 10.1002/jmri.20467

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  26 in total

Review 1.  Identification of patients with hereditary haemochromatosis by magnetic resonance imaging and spectroscopic relaxation time measurements.

Authors:  C Thomsen; P Wiggers; H Ring-Larsen; E Christiansen; J Dalhøj; O Henriksen; P Christoffersen
Journal:  Magn Reson Imaging       Date:  1992       Impact factor: 2.546

2.  In vivo measurement of T*2 and field inhomogeneity maps in the human heart at 1.5 T.

Authors:  S B Reeder; A Z Faranesh; J L Boxerman; E R McVeigh
Journal:  Magn Reson Med       Date:  1998-06       Impact factor: 4.668

3.  Blood oxygen saturation assessment in vivo using T2* estimation.

Authors:  D Li; Y Wang; D J Waight
Journal:  Magn Reson Med       Date:  1998-05       Impact factor: 4.668

4.  Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths.

Authors:  J W Bulte; G F Miller; J Vymazal; R A Brooks; J A Frank
Journal:  Magn Reson Med       Date:  1997-04       Impact factor: 4.668

5.  Magnetic resonance imaging kappa-space segmentation using phase-encoding groups the accuracy of quantitative measurements of pulsatile flow.

Authors:  H Li; G D Clarke; M NessAvier; H Liu; R Peshock
Journal:  Med Phys       Date:  1995-04       Impact factor: 4.071

6.  Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and T1 measurements.

Authors:  C M Wacker; M Bock; A W Hartlep; G Beck; G van Kaick; G Ertl; W R Bauer; L R Schad
Journal:  Magn Reson Med       Date:  1999-04       Impact factor: 4.668

7.  Cardiac alterations in 36 consecutive patients with idiopathic haemochromatosis: polygraphic and echocardiographic evaluation.

Authors:  G Cecchetti; A Binda; A Piperno; F Nador; S Fargion; G Fiorelli
Journal:  Eur Heart J       Date:  1991-02       Impact factor: 29.983

8.  Survival in medically treated patients with homozygous beta-thalassemia.

Authors:  N F Olivieri; D G Nathan; J H MacMillan; A S Wayne; P P Liu; A McGee; M Martin; G Koren; A R Cohen
Journal:  N Engl J Med       Date:  1994-09-01       Impact factor: 91.245

9.  Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model.

Authors:  P Liu; M Henkelman; J Joshi; P Hardy; J Butany; M Iwanochko; M Clauberg; M Dhar; D Mai; S Waien; N Olivieri
Journal:  Can J Cardiol       Date:  1996-02       Impact factor: 5.223

Review 10.  Diagnosis and management of iron-induced heart disease in Cooley's anemia.

Authors:  M Jessup; C S Manno
Journal:  Ann N Y Acad Sci       Date:  1998-06-30       Impact factor: 5.691

View more
  59 in total

1.  R2* imaging of transfusional iron burden at 3T and comparison with 1.5T.

Authors:  Pippa Storey; Alexis A Thompson; Christine L Carqueville; John C Wood; R Andrew de Freitas; Cynthia K Rigsby
Journal:  J Magn Reson Imaging       Date:  2007-03       Impact factor: 4.813

2.  T2 star relaxation times for assessment of articular cartilage at 3 T: a feasibility study.

Authors:  Tallal Charles Mamisch; Timothy Hughes; Timothy J Mosher; Christoph Mueller; Siegfried Trattnig; Chris Boesch; Goetz Hannes Welsch
Journal:  Skeletal Radiol       Date:  2011-04-19       Impact factor: 2.199

3.  Cardiac T2* and lipid measurement at 3.0 T-initial experience.

Authors:  Declan P O'Regan; Martina F Callaghan; Julie Fitzpatrick; Rossi P Naoumova; Joseph V Hajnal; Stephan A Schmitz
Journal:  Eur Radiol       Date:  2007-11-23       Impact factor: 5.315

Review 4.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

5.  Atrial dysfunction as a marker of iron cardiotoxicity in thalassemia major.

Authors:  Walter Li; Thomas Coates; John C Wood
Journal:  Haematologica       Date:  2008-02       Impact factor: 9.941

6.  Cardiac R2* values are independent of the image analysis approach employed.

Authors:  Antonella Meloni; Hugh Young Rienhoff; Amber Jones; Alessia Pepe; Massimo Lombardi; John C Wood
Journal:  Magn Reson Med       Date:  2013-10-01       Impact factor: 4.668

Review 7.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

8.  Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.

Authors:  Antonella Meloni; Jon Detterich; Vasili Berdoukas; Alessia Pepe; Massimo Lombardi; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2013-02-06       Impact factor: 10.047

9.  Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification.

Authors:  Taigang He; Peter D Gatehouse; Gillian C Smith; Raad H Mohiaddin; Dudley J Pennell; David N Firmin
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

10.  Pulmonary hypertension in well-transfused thalassemia major patients.

Authors:  Antonella Meloni; Jon Detterich; Alessia Pepe; Paul Harmatz; Tom D Coates; John C Wood
Journal:  Blood Cells Mol Dis       Date:  2014-11-24       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.